BBVA USA’s Genmab GMAB Stock Holding History

BBVA USA’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$73K	Sell	1,677 -763	-31%	-$34.3K	﹤0.01%	592
2021 Q2	$100K	Buy	+2,440	New	+$94.2K	0.01%	562

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BBVA USA's GMAB Position: Q3 2021 in Review

BBVA USA reduced its Genmab (GMAB) stake by 31% in Q3 2021, selling an estimated $34.3K and leaving 1,677 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #592.

BBVA USA first reported a position in GMAB in Q2 2021 and has held it in 2 quarters since. The position peaked at $100K in Q2 2021. 211 funds tracked by Wall St. Rank hold GMAB as of Q3 2021.

BBVA USA held 1,677 shares of Genmab worth $73K as of Q3 2021.
BBVA USA sold 763 Genmab shares in Q3 2021, an estimated $34.3K.
Genmab made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #592 holding.
BBVA USA first reported a position in Genmab in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Genmab position peaked at $100K in Q2 2021.
211 funds tracked by Wall St. Rank held Genmab as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.